Fra Zerohedge / FT
Just as we suspected, the sketchy Statnews report authored by the increasingly sketchy Adam Feuerstein, and claiming that Gilead’s remdesivir had achieved miraculous results on patients in a small preliminary University of Chicago study has been exposed as complete BS.
In response to the fake STATNews report which managed to boost the entire stock market one week ago – despite our loud warning that the article came from a person who tends to do the bidding of well-paying hedge fund clients – the FT just reported that Gilead’s “miracle drug” remdesivir has flopped in during its first clinical trial.
Donato Paolo Mancini@donatopmanciniFT SCOOP: Gilead’s potential coronavirus candidate remdesivir has flopped in its first randomised clinical trial, according to draft documents published accidentally by the World Health Organisation and seen by the Financial Times. With @hannahkuchler https://www.ft.com/content/0a4872d1-4cac-4040-846f-ce32daa09d99 …
